Law360, New York (March 16, 2005, 12:00 AM ET) -- Raising the specter of compulsory licensing, Brazil's government health ministry has given U.S. drug makers Abbot Laboratories, Merck & Co. and Gilead Sciences Inc. until April 4 to agree on a schedule to transfer technology for the production of some of their AIDS drugs.
The drugs in question, Abbott's combination pill of the protease inhibitors Lopinavir and Ritonavir, Merck & Co's reverse transcriptase inhibitor Efavirenz, and Gilead Science Inc.'s Tenofovir, account for two thirds of the government's budget for imported AIDS drugs.
If the companies don't...
Brazil Threatens U.S. AIDS Drug Makers With Compulsory Licensing
To view the full article, take a free trial now.
